Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating aspirin versus rivaroxaban for thromboprophylaxis in patients with multiple myeloma to prevent venous thromboembo…
-
CLINICAL_TRIALS research · 2025-07-18Clinical Trial Update: Mosaic Trial for Stem Cell Transplant Recipients [NA]
This clinical trial update indicates the Mosaic trial for stem cell transplant recipients is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: CAR-T vs. Auto-SCT: Which Works Better for New Myeloma Patients? [Phase 2]
Phase 2 trial update comparing CAR-T cell therapy versus autologous stem cell transplant for newly diagnosed multiple myeloma; the study is …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible [NA]
A clinical trial from Xuzhou Medical University is evaluating anti-BCMA CAR-T therapy in newly diagnosed multiple myeloma patients who are t…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Quality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
This clinical trial update describes a study comparing quality of life and treatment outcomes in relapsed/refractory multiple myeloma patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: MMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM [Phase 2]
The MMRC Horizon One adaptive platform trial evaluating therapies for relapsed or refractory multiple myeloma is in Phase 2 and currently re…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Completed Phase 1/2 trial evaluating safety, tolerability, and preliminary clinical activity of Forimtamig-based treatment combinations in r…
-
EMA approval · 2025-07-14EMA Authorised: Pomalidomide Krka (Pomalidomide) — Krka, d.d., Novo mesto
The EMA authorised Pomalidomide Krka for the treatment of multiple myeloma.
-
CLINICAL_TRIALS research · 2025-07-14Clinical Trial Update: MYeloma Resistance And Clonal Evolution
A Nantes University Hospital-sponsored clinical trial called "MYeloma Resistance And Clonal Evolution" is currently recruiting. The study fo…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS) [NA]
A Washington University School of Medicine trial (WU-PE-CGS) is currently recruiting participants for cholangiocarcinoma, multiple myeloma, …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties [NA]
A music therapy study at Memorial Sloan Kettering Cancer Center is evaluating whether music-based interventions can help cognitive difficult…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma [NA]
A clinical trial is evaluating low-dose radiotherapy to relieve bone metastasis–related pain in patients with multiple myeloma and is curren…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: A Clinical Study of Allogeneic CD19/BCMA CAR-T Cells for the Treatment of R/R B-cell Malignant Tumors [EARLY_Phase 1]
This is an early-phase study evaluating allogeneic CD19/BCMA CAR-T cells for relapsed/refractory B-cell malignancies, currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Lifestyle Intervention for Veterans With Blood Cancer: Tele-Intervention [NA]
This is a clinical trial evaluating a tele-delivered lifestyle intervention for veterans with blood cancers, and it is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 first-in-human study of AMG 176 in relapsed or refractory multiple myeloma and acute myeloid leukemia was terminated with results po…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: A Study of MCARH109 and MCARH125 in People With Multiple Myeloma [Phase 1]
A Phase 1 clinical trial update on MCARH109 and MCARH125 in people with multiple myeloma, including refractory and relapsed disease, current…
-
FDA approval · 2025-07-08FDA Approved: ELREXFIO — Supplemental Application (U.S. Pharmaceuticals)
The FDA approved a supplemental application for ELREXFIO (elranatamab-BCMM) filed by U.S. Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Isa-RVD Study in Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating Isa-RVD (isatuximab plus lenalidomide, bortezomib, and dexamethasone) for newly diagnosed multiple myeloma, with …
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: Horizon Two Adaptive Platform Study in High Risk Newly Diagnosed Multiple Myeloma [Phase 2]
Phase 2 adaptive platform trial Horizon Two for high-risk newly diagnosed multiple myeloma is currently not recruiting.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
This clinical trial update describes the use of the PET imaging agent 18F-fluorothymidine (18F-FLT) in cancer patients to assess tumor proli…
-
CLINICAL_TRIALS withdrawal · 2025-07-03Clinical Trial Update: Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL [Phase 1]
The Phase 1 study of BMF-219, Biomea Fusion's covalent menin inhibitor, in adults with AML, ALL, DLBCL, multiple myeloma, and CLL/SLL has be…
-
CLINICAL_TRIALS research · 2025-07-03Clinical Trial Update: Lenalidomide Maintenance in Plasma Cell Myeloma [Phase 2]
A Phase 2 clinical trial of lenalidomide as maintenance therapy for plasma cell myeloma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-07-02Clinical Trial Update: DARA RVD For High Risk SMM [Phase 2]
A Phase 2 trial investigates adding daratumumab to the RVD regimen for high-risk Smoldering multiple myeloma and multiple myeloma; the study…
-
CLINICAL_TRIALS trial_result · 2025-07-02Clinical Trial Update: Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma [NA]
This clinical trial update describes a Phase II study investigating the safety and efficacy of a combined CAR-T cell therapy after autologou…
-
CLINICAL_TRIALS research · 2025-07-01Clinical Trial Update: Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy [Phase 2]
Phase 2 clinical trial for patients with multiple myeloma who do not qualify for TT4 and TT5 protocols due to prior therapy; the study is cu…